Home » Topics » Regulatory » Patents

Patents
RSS

Bayer Schering Pharma divulges Wnt signaling inhibitors

Oct. 8, 2015

Capella Therapeutics patents EGFR inhibitors

Oct. 8, 2015

Bristol-Myers Squibb introduces NS5B inhibitors

Oct. 8, 2015

Daiichi Sankyo divulges EZH1/EZH2 inhibitors

Oct. 8, 2015

Chungnam National University introduces cardiac myosin activators

Oct. 7, 2015

Synta Pharmaceuticals HSP90-targeted SDC-TRAPs

Oct. 7, 2015

Beijing Hanmi patents ROR-gamma modulators

Oct. 7, 2015

Janssen discloses c-Ros-1 inhibitors

Oct. 7, 2015

Merck & Co. reports TrkA inhibitors

Oct. 7, 2015

AstraZeneca introduces ENaC modulators

Oct. 6, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...